Table 3 Effect of Doxorubicin (DOX) and different treatments of AHE on hepatic phase II antioxidant enzymes and GSH profile

19.61 ± 0.283^b

163.6 ± 0.656^b

142.6 ± 0.57^b

336.2 ± 0.564^b

139.5 ± 1.164^b

10.46 ± 0.660^a

101.4 ± 0.599^a

99.72 ± 1.08^a

141.6 ± 0.296^a

92.58 ± 0.752^a

20.11 ± 0.158^b

164.2 ± 0.677^b

142.7 ± 0.89^b

336.3 ± 0.999^b

139.8 ± 0.355^b

12.50 ± 0.397^{a, d}

134.8 ± 0.81^{a, b, d}

118.7 ± 1.81^{a, b, d*}

199.2 ± 1.610^{a, b, d}

111.3 ± 0.874^{a, b, d}

17.43 ± 0.599^{a*, b, c}

149.8 ± 0.91^{a, b, c}

130.8 ± 1.86^{a**, b, c**}

306.8 ± 0.779^{a, b, c}

130.5 ± 1.192^{a, b, c}

17.32 ± 0.387^{a*, b}

152.7 ± 1.671^{a, b}

128.3 ± 2.82^{a, b}

307.9 ± 1.246^{a, b}

130.9 ± 0.344^{a, b}